ClinicalTrials.gg
Not yet recruitingNCT07469280Updated Mar 23, 2026

High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea

An interventional study of High-Intensity Progressive Inspiratory Muscle Training (IMT) in Obesity, Class III, Sleep Apnea, Obstructive and Inspiratory Muscle Training, sponsored by University of the State of Santa Catarina. Not yet recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by University of the State of Santa Catarina · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 285 studies in Obesity with a site in Brazil — 41 open to participants now, 61 under way, 27 of them phase 3. Obesity · Brazil.

Planned enrollment
237th of 251
10 · median 60
Started
2026
with 28 others
No phase
170 of 285
20 open now
Primary completion
2027-05
later than 30 of 60 live
Registered
265th of 285
by date

Among the 285 studies in Obesity with a site in Brazil, this one is the 237th largest by planned enrollment of the 251 interventional ones that give a count, is one of 29 that started in 2026, is one of 170 with no phase, reaches primary completion later than 30 of the 60 other live ones, and was the 265th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

41 of the 285 studies in Obesity with a site in Brazil are open now. Recruiting first, the newest first:

36 more — sign in →

All 41 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 285 studies in Obesity with a site in Brazil, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate the feasibility and effects of a 12-week high-intensity progressive Inspiratory Muscle Training (IMT) program in individuals with Class III obesity (BMI ≥ 40 kg/m²) and obstructive sleep apnea (OSA). Using a single-case experimental design (SCED) with multiple baselines, the study will investigate whether this respiratory intervention can reduce the severity of sleep apnea, as measured by the Apnea-Hypopnea Index (AHI), and improve inspiratory muscle strength and sleep quality. Participants will perform daily training sessions using a resistive loading device (POWERbreathe), with intensity progressing from 40% to 90% of their maximum inspiratory pressure.

03

Conditions studied

  • Obesity, Class III
  • Sleep Apnea, Obstructive
  • Inspiratory Muscle Training

Keywords

  • Class III obesity
  • Inspiratory muscle training
  • Obstructive sleep apnea
  • Single-case experimental design
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: -Adults (≥18 years).

  • Of both genders.
  • Class III obesity ( > 40 kg/m²).
  • Diagnosis of OSA.
  • Without neurological conditions that would prevent them from responding to the study assessments.

Exclusion Criteria:

  • Systemic diseases (pulmonary, cardiac or renal).
  • Are using medications that may affect muscle performance.
  • Are currently using CPAP therapy.
  • Conditions that could compromise adherence to the study protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Experimental Group: High-Intensity IMT

    Participants will undergo a progressive high-intensity Inspiratory Muscle Training (IMT) program using a resistive loading device (POWERbreathe).

    Device: High-Intensity Progressive Inspiratory Muscle Training (IMT)

Interventions

  • DeviceHigh-Intensity Progressive Inspiratory Muscle Training (IMT)

    "The intervention consists of 12 weeks of inspiratory muscle training performed 5 days per week. Each session includes 30 breaths through a resistive loading device (POWERbreathe). The training intensity starts at 40% of the Maximum Inspiratory Pressure (MIP) and progressively increases to 90% of MIP. Training load is adjusted weekly based on new MIP measurements to ensure high-intensity stimulus. Compliance and adverse events will be monitored through a training diary."

06

What researchers measure

Primary outcomes

  1. Apnea-Hypopnea Index (AHI)

    Number of apnea and hypopnea events per hour of sleep, measured via portable polygraphy (Type III)

    Time frame: Baseline (Phase A - three measurements) and Post-Intervention (Phase B - 12th week).

Secondary outcomes

  1. Maximum Inspiratory Pressure (MIP)

    Assessment of inspiratory muscle strength using a digital pressure manometer.

    Time frame: Weekly assessments throughout Phase A (3 to 5 weeks) and Phase B (12 weeks).

  2. Epworth Sleepiness Scale (ESS) score

    Validated questionnaire to assess the level of daytime sleepiness. Scores range from 0 to 24, where higher scores indicate greater sleepiness.

    Time frame: Baseline and Post-Intervention (12th week).

  3. Pittsburgh Sleep Quality Index (PSQI) global score

    Questionnaire to assess sleep quality over a one-month period. Scores range from 0 to 21; higher scores indicate poorer sleep quality.

    Time frame: Baseline and Post-Intervention (12th week).

  4. International Physical Activity Questionnaire (IPAQ) - Short Form

    Assessment of physical activity level. It classifies participants as sedentary, irregularly active, active, or very active based on metabolic equivalent task (MET-min/week).

    Time frame: Baseline and Post-Intervention (12th week).

  5. Borg Rating of Perceived Exertion (RPE)

    Scale ranging from 6 to 20 used to monitor the intensity of the respiratory effort during the IMT sessions.

    Time frame: Daily during the 12 weeks of intervention (Phase B).

  6. Quebec Sleep Questionnaire (QSQ)

    A disease-specific quality of life questionnaire for obstructive sleep apnea. It consists of 32 items divided into five domains: daytime sleepiness, diurnal symptoms, nocturnal symptoms, emotions, and social interactions. Each item is scored on a 7-point Likert scale, where higher scores indicate better quality of life.

    Time frame: Baseline (Phase A) and Post-Intervention (12th week of Phase B).

07

Study locations

1 site
  • Santa Catarina State University - CEFID (Center of Health and Sport Sciences)
    Florianópolis, Santa Catarina 88080-350, Brazil
08

References and documents

Publications

  • GRANVILE, A. A. B. B.; BORGES, A. C. L.; RUAS, G. EFEITOS DO TREINAMENTO DE ALTA E BAIXA INTENSIDADE NA MUSCULATURA INSPIRATÓRIA EM INDIVÍDUOS OBESOS MÓRBIDOS: ESTUDO RANDOMIZADO CONTROLADO. Revista Brasileira de Obesidade, Nutrição e Emagrecimento, p. 469-478, dez. 2017.
  • Dar JA, Mujaddadi A, Moiz JA. Effects of inspiratory muscle training in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. Sleep Sci. 2022 Oct-Dec;15(4):480-489. doi: 10.5935/1984-0063.20220081. PubMed 36419804 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for May 2027, 12 months later.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 12 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 9, 2026
First posted
Mar 13, 2026
StartEst.
May 1, 2026
Primary completionEst.
May 1, 2027
CompletionEst.
Dec 1, 2027
Last update
Mar 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07469280
Lead sponsor
University of the State of Santa Catarina
Responsible party
Karina Abreu (Principal Investigator, University of the State of Santa Catarina) — Principal investigator
First posted
Mar 13, 2026
Start date
May 1, 2026 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Mar 23, 2026

Study contacts

Karina Abreu, MSc
Contact
fisioterapeutakarina.abreu@gmail.com
+55 (48) 998230417
Darlan Laurício Matte, PhD
Contact
darlan.matte@udesc.br
+55 48 3364 8696
Darlan Laurício Matte, PhD
study chair · Santa Catarina State University (UDESC)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion